The Affordable Care Act’s new prescription opioid addiction drug plan is being hailed by doctors and pharmacists as a major breakthrough for patients with chronic pain, according to a recent study.
According to the findings, the program, which is the first phase of a new opioid-focused approach to chronic pain management, is being heralded as a “game-changer.”
The National Alliance on Mental Illness, an advocacy group, has touted the plan as the most comprehensive treatment plan yet for opioid use disorder in the United States.
The study found that over one million people are using opioids for chronic pain and about 40% of them are under 30 years old.
More than 20 million Americans are on the program and the study found those under the age of 30 are more likely to be taking opioids than older adults.
The findings also indicate that the opioid treatment plan is not only effective at reducing the risk of overdose and dependence, but it also improves patient outcomes.
The opioid-treatment plan was released by the U.S. Centers for Disease Control and Prevention (CDC) in March.
The CDC released data last year showing that more than a third of adults over the age 20 are taking opioids.
Dr. Jeffrey Warshawsky, a senior medical officer at the American Academy of Pain Medicine and an author of the new study, told ABC News that the findings show that the new approach is “a game-changers for pain patients and physicians who care for them.”
The plan’s implementation is expected to be fully phased in by the end of the year.
Dr Warshawawsky said there are still some questions to be answered about how effective the opioid program will be in terms of the numbers of people taking it and how long it will take for patients to see their doctor.
The plan was initially designed to address the problem of opioid addiction, but now, Warshavsky said, the focus is shifting to the treatment of people with a chronic pain condition that involves chronic symptoms such as depression, anxiety and muscle spasms.
He said the new prescription drug plan will address many of these symptoms as well as improve the quality of life for people with chronic conditions, such as diabetes and heart disease.
He added that this plan will also address the stigma associated with prescription opioids.
“In our study, we found that a significant portion of the population will be on the opioids and they will see their doctors.
They will see a doctor who is willing to prescribe them opioids and give them opioids,” Warshajsky told ABC.”
This is a game-changing opportunity for physicians and patients to get off opioids and get back on their feet,” he added.
The new plan, he said, will help patients better manage pain by providing opioids to them when they need them most.
It will also allow doctors and other health care providers to prescribe opioids to patients who have symptoms that are not a symptom of a chronic disease.
The Centers for Medicare and Medicaid Services (CMS) said that the prescription drug plans will provide an estimated 5.8 million people with pain a better quality of lives.
The plans will also help provide relief to patients and their families, improve access to quality medical care and reduce costs, CMS said.
Dr Charles Rupp, the executive director of the American Association of Pain Physicians, said that as more and more people are diagnosed with chronic, disabling pain, they need to have access to opioids.
He also said the program will reduce the stigma surrounding opioid use and help people feel more comfortable talking to their doctors about their pain.
“The new approach will help reduce the need for opioids, and we’re very hopeful that it will reduce stigma and provide access to the opioid that is the best treatment option for these people,” he said.
Follow NBC News Investigations on Twitter and Facebook.